Can prednisone precipitate confusion or delirium, and how should it be managed?

Prednisone Can Precipitate Confusion and Delirium

Yes, prednisone definitively causes psychiatric disturbances including confusion, delirium, and psychosis, and should be discontinued or dose-reduced when these symptoms occur. 1

Mechanism and Incidence

Corticosteroid-induced psychiatric disease occurs in approximately 10% of patients treated with prednisone ≥1 mg/kg, manifesting primarily as mood disorders (93%) rather than psychosis, though confusion and delirium are well-documented complications 2. The FDA drug label explicitly lists psychiatric derangements ranging from euphoria, insomnia, mood swings, and personality changes to severe depression and frank psychotic manifestations, as well as convulsions, delirium, dementia, depression, hallucinations, and impaired cognition 1.

The risk increases dramatically with dose: psychiatric complications rise rapidly once daily prednisone exceeds 40 mg 3. However, even low doses (15 mg or 5 mg) can precipitate severe delirium in vulnerable elderly patients 4.

Risk Factors to Identify

• Age: Elderly patients are at substantially higher risk 4, 5
• Female sex: Women have increased susceptibility 5
• Prior corticosteroid-induced psychiatric effects: Strong predictor of recurrence 3
• Damaged blood-brain barrier and hypoalbuminemia: Increase risk 3
• Multiple vulnerabilities: Frailty, polypharmacy, cognitive impairment 4

Notably, the elderly and those with previous psychiatric diagnoses are NOT at increased risk compared to baseline population 5.

Clinical Presentation

Corticosteroid-induced confusion presents as:

• Acute confusional state/delirium: Acute onset, fluctuating consciousness, decreased attention 2
• Psychosis: Delusions, hallucinations (less common than mood symptoms) 2
• Mood disturbances: Depression, mania, emotional lability 1, 6
• Cognitive impairment: Memory deficits, impaired concentration, disorientation 1

The symptoms typically develop within days of starting therapy 4 and can range from mild confusion to severe agitation with verbal and physical aggression 4.

Management Algorithm

1. Immediate Assessment

• Confirm delirium using validated tools (CAM-ICU or ICDSC) 7, 8
• Rule out other precipitating causes: infections, metabolic disturbances, electrolyte abnormalities, hypoxia 2, 9
• Review all medications for other deliriogenic agents 9
• Obtain basic labs: electrolytes, glucose, calcium, magnesium, renal/hepatic function 7

2. Primary Intervention: Corticosteroid Management

Discontinue or rapidly taper prednisone if medically feasible 9. This is the definitive treatment—delirium typically resolves completely after prednisone cessation 4. One case report documented complete resolution of severe delirium after stopping low-dose prednisone, though the patient required 36 days hospitalization due to complications 4.

If corticosteroids cannot be stopped due to underlying medical necessity:

• Reduce to lowest effective dose 1
• Consider switching to corticosteroid with less CNS penetration
• Implement close psychiatric monitoring 3

3. Non-Pharmacological Interventions (First-Line)

Before using medications, maximize 9:

• Reorientation strategies and cognitive stimulation
• Sleep hygiene optimization
• Minimize physical restraints (associated with worse outcomes) 8
• Ensure adequate hydration and nutrition
• Mobilization when safe
• Sensory aids (glasses, hearing aids)
• Familiar objects and family presence

4. Pharmacological Management (When Non-Pharmacological Fails)

For moderate delirium with agitation 9, 10:

• Haloperidol 0.5-1 mg PO/IV/SC stat (can repeat q1-2h PRN)
• Risperidone 0.5 mg PO stat (q12h if scheduled dosing needed)
• Olanzapine 2.5-5 mg PO stat (q12-24h if scheduled dosing needed)
• Quetiapine 12.5-25 mg PO stat (q12h if scheduled dosing needed)

For severe delirium with severe agitation 9, 10:

• Haloperidol higher doses with close monitoring
• Chlorpromazine (only in bed-bound patients due to hypotension risk)
• Benzodiazepines (lorazepam 0.5-1 mg or midazolam 1-2.5 mg) may be added for refractory agitation, but only after therapeutic antipsychotic levels achieved to prevent paradoxical excitation 9, 10

Critical caveat: Benzodiazepines should NOT be used as monotherapy for delirium unless treating alcohol/benzodiazepine withdrawal 9, 10. They can worsen confusion and increase fall risk 9.

5. Prophylaxis for High-Risk Patients

For patients requiring future corticosteroid courses who have prior steroid-induced psychosis/mania 3:

• Lithium or olanzapine represent best prophylactic choices
• Small trials support prophylactic use of various agents
• Prompt liaison psychiatry involvement recommended 3

Monitoring and Follow-Up

• Assess delirium severity at least twice daily using validated tools 2
• Monitor for complications: falls, aspiration, pressure ulcers, functional decline 4
• Document response to interventions
• Taper psychotropic medications once delirium resolves 9
• Warn patients and caregivers about potential neuropsychiatric effects before initiating corticosteroids 1, 3

Critical Pitfalls to Avoid

1. Attributing confusion to other causes without considering prednisone: Even low doses can cause severe delirium in vulnerable patients 4
2. Using benzodiazepines as first-line treatment: This worsens delirium except in alcohol/benzodiazepine withdrawal 9, 10
3. Continuing corticosteroids at same dose: Dose reduction or discontinuation is the definitive treatment 9, 4
4. Failing to warn patients preemptively: All patients starting corticosteroids should be counseled about neuropsychiatric risks 1, 3
5. Using physical restraints liberally: Associated with worse outcomes including more agitation and longer ICU stays 8

Long-Term Consequences

Corticosteroid-induced delirium can lead to 4:

• Prolonged hospitalization (up to 36 days documented)
• Significant weight loss and malnutrition
• Increased care needs at discharge
• Functional decline
• Increased mortality risk (delirium doubles mortality if missed) 7